目前的证据表明,布莱维尔提德作为单一疗法与结合治疗与基化干扰素治疗型肝炎的治疗相比,是有效的
Juan Carlos Ruiz-Cobo1,2,3,4, Adriana Palom3,4, Mar Riveiro-Barciela1,2,3,4
1Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
Expert review of anti-infective therapy
|October 24, 2025
概括
布列维尔提德 (BLV) 有效治疗慢性三角肝炎 (CHD),长期使用可以改善结果. 对于这种D型肝炎治疗没有反应的患者,需要进一步的研究.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 病毒学 病毒学
- 药理学 药理学是指药理学的学科.
背景情况:
- 自20世纪90年代以来,基化干扰素α-2a (PEG-IFN) 已在慢性肝炎三角形 (CHD) 治疗中非标签使用.
- 布列维尔提德 (BLV) 是首个被批准用于补偿性心血管疾病的药物,是第一类进入抑制剂.
- 关于治疗终点,临床结果,持续时间和PEG-IFN联合治疗的证据缺口存在.
研究的目的:
- 提供关于BLV治疗心脏病的现有证据的全面审查.
- 评估BLV作为单一疗法和与PEG-IFN结合使用.
- 为满足心血管疾病治疗的未满足需求.
主要方法:
- 在PubMed的文献搜索 (至2025年7月),EMA报告和会议摘要.
- 对临床试验数据和关于BLV疗效的真实世界研究的审查.
- 分析BLV在治疗慢性肝炎delta中的作用.
主要成果:
- 布列维二毫克在患有或没有晚期肝病的患者中有效治疗心脏病.
- 长期的BLV治疗可能会改善反应率,并促进HDV感染肝细胞的丧失.
- 观察到持续的治疗外反应的潜力.
结论:
- BLV是一种有效的治疗慢性型肝炎的方法.
- 长期用BLV治疗显示出持续反应的前景.
- 对于那些对BLV.不反应的患者,需要新的策略.
相关概念视频
Hepatitis
99
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
99
Inhibitors of Viral Protein Synthesis
73
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
73
Viral Hepatitis I: Introduction
28
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
28


